Annual EBIT
-$95.31 M
-$5.47 M-6.08%
December 31, 2023
Summary
- As of February 12, 2025, XFOR annual earnings before interest & taxes is -$95.31 million, with the most recent change of -$5.47 million (-6.08%) on December 31, 2023.
- During the last 3 years, XFOR annual EBIT has fallen by -$36.02 million (-60.74%).
- XFOR annual EBIT is now -647.78% below its all-time high of -$12.75 million, reached on December 31, 2015.
Performance
XFOR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$34.27 M
-$127.29 M-136.84%
September 30, 2024
Summary
- As of February 12, 2025, XFOR quarterly earnings before interest & taxes is -$34.27 million, with the most recent change of -$127.29 million (-136.84%) on September 30, 2024.
- Over the past year, XFOR quarterly EBIT has dropped by -$127.29 million (-136.84%).
- XFOR quarterly EBIT is now -136.84% below its all-time high of $93.03 million, reached on June 30, 2024.
Performance
XFOR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$8.32 M
-$33.62 M-132.90%
September 30, 2024
Summary
- As of February 12, 2025, XFOR TTM earnings before interest & taxes is -$8.32 million, with the most recent change of -$33.62 million (-132.90%) on September 30, 2024.
- Over the past year, XFOR TTM EBIT has dropped by -$33.62 million (-132.90%).
- XFOR TTM EBIT is now -132.90% below its all-time high of $25.30 million, reached on June 30, 2024.
Performance
XFOR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XFOR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.1% | -136.8% | -132.9% |
| 3 y3 years | -60.7% | -136.8% | -132.9% |
| 5 y5 years | -192.7% | -101.3% | +83.6% |
XFOR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.1% | at low | -136.8% | +37.2% | -132.9% | +93.4% |
| 5 y | 5-year | -88.1% | at low | -136.8% | +37.2% | -132.9% | +93.4% |
| alltime | all time | -647.8% | at low | -136.8% | +37.2% | -132.9% | +93.4% |
X4 Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$34.27 M(-136.8%) | -$8.32 M(-132.9%) |
| Jun 2024 | - | $93.03 M(-286.5%) | $25.30 M(-120.7%) |
| Mar 2024 | - | -$49.87 M(+189.8%) | -$122.28 M(+28.3%) |
| Dec 2023 | -$95.31 M(+6.1%) | -$17.21 M(+2568.4%) | -$95.31 M(-10.1%) |
| Sep 2023 | - | -$645.00 K(-98.8%) | -$106.05 M(-15.8%) |
| Jun 2023 | - | -$54.55 M(+138.1%) | -$125.98 M(+37.4%) |
| Mar 2023 | - | -$22.91 M(-18.0%) | -$91.72 M(+2.1%) |
| Dec 2022 | -$89.85 M(+5.7%) | -$27.95 M(+35.8%) | -$89.85 M(-1.5%) |
| Sep 2022 | - | -$20.58 M(+1.4%) | -$91.18 M(+1.5%) |
| Jun 2022 | - | -$20.29 M(-3.5%) | -$89.85 M(+1.8%) |
| Mar 2022 | - | -$21.03 M(-28.2%) | -$88.29 M(+3.8%) |
| Dec 2021 | -$85.04 M(+43.4%) | -$29.28 M(+52.1%) | -$85.04 M(+15.8%) |
| Sep 2021 | - | -$19.25 M(+2.8%) | -$73.44 M(+3.5%) |
| Jun 2021 | - | -$18.73 M(+5.3%) | -$70.94 M(+6.4%) |
| Mar 2021 | - | -$17.78 M(+0.6%) | -$66.67 M(+12.4%) |
| Dec 2020 | -$59.30 M | -$17.68 M(+5.5%) | -$59.30 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$16.75 M(+15.9%) | -$51.90 M(-0.5%) |
| Jun 2020 | - | -$14.46 M(+38.9%) | -$52.18 M(+3.1%) |
| Mar 2020 | - | -$10.41 M(+1.1%) | -$50.59 M(-0.1%) |
| Dec 2019 | -$50.66 M(+55.6%) | -$10.29 M(-39.6%) | -$50.66 M(+26.5%) |
| Sep 2019 | - | -$17.03 M(+32.3%) | -$40.06 M(+19.0%) |
| Jun 2019 | - | -$12.87 M(+22.9%) | -$33.67 M(+3.1%) |
| Mar 2019 | - | -$10.47 M(-3446.3%) | -$32.68 M(+0.3%) |
| Dec 2018 | -$32.56 M(+2.4%) | $313.00 K(-102.9%) | -$32.56 M(-25.6%) |
| Sep 2018 | - | -$10.64 M(-10.4%) | -$43.79 M(-1.4%) |
| Jun 2018 | - | -$11.87 M(+14.6%) | -$44.41 M(+17.5%) |
| Mar 2018 | - | -$10.36 M(-5.0%) | -$37.80 M(+18.9%) |
| Dec 2017 | -$31.80 M(+55.4%) | -$10.91 M(-3.0%) | -$31.80 M(+25.1%) |
| Sep 2017 | - | -$11.26 M(+114.0%) | -$25.41 M(+79.5%) |
| Jun 2017 | - | -$5.26 M(+20.5%) | -$14.16 M(+59.1%) |
| Mar 2017 | - | -$4.37 M(-3.6%) | -$8.89 M(+96.4%) |
| Dec 2016 | -$20.46 M(+60.5%) | -$4.53 M | -$4.53 M |
| Dec 2015 | -$12.75 M | - | - |
FAQ
- What is X4 Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual EBIT year-on-year change?
- What is X4 Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly EBIT year-on-year change?
- What is X4 Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM EBIT year-on-year change?
What is X4 Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of XFOR is -$95.31 M
What is the all time high annual EBIT for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual earnings before interest & taxes is -$12.75 M
What is X4 Pharmaceuticals annual EBIT year-on-year change?
Over the past year, XFOR annual earnings before interest & taxes has changed by -$5.47 M (-6.08%)
What is X4 Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of XFOR is -$34.27 M
What is the all time high quarterly EBIT for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly earnings before interest & taxes is $93.03 M
What is X4 Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, XFOR quarterly earnings before interest & taxes has changed by -$127.29 M (-136.84%)
What is X4 Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of XFOR is -$8.32 M
What is the all time high TTM EBIT for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM earnings before interest & taxes is $25.30 M
What is X4 Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, XFOR TTM earnings before interest & taxes has changed by -$33.62 M (-132.90%)